Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04644
Species: Homo sapiens
Position : chr14:97720000-97780000
Year: 2007
Title: Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  17308084
MONDO: MONDO:0004963
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Peer
CVCL ID: CVCL_1913
Cell Type: T lymphoblast
Cell Ontology ID: CL:0000084
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: DNase-seq
Low Throughput Method: DNA inhibitory treatment; ChIP-RT-qPCR; RT-RT-qPCR; Western blot; FISH
About Target Gene
Target gene : NKX2-5
About TF
TF name : SPI1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
SPI1 C-MYB transcription factor network pid 87
SPI1 ERK cascade ( FGF8 signaling (Mouse) ) inoh 17
SPI1 ERK cascade ( FGF8 signaling (Xenopus) ) inoh 17
SPI1 FGF8 signaling pathway(Mouse) ( FGF8 signaling (Mouse) ) inoh 20
SPI1 FGF8 signaling pathway(Xenopus) ( FGF8 signaling (Xenopus) ) inoh 18
SPI1 Glucocorticoid receptor regulatory network pid 85
SPI1 IL4-mediated signaling events pid 66
SPI1 IL4 netpath 75
SPI1 Interleukin signaling pathway panther 86
SPI1 RANKL netpath 84
SPI1 Regulation of retinoblastoma protein pid 67
SPI1 Validated targets of C-MYC transcriptional repression pid 63
SPI1 Pathways in cancer kegg 321
SPI1 Acute myeloid leukemia kegg 53
SPI1 Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 wikipathways 26
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer